Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections

NCT07610967 is registered in ClinicalTrials.gov with David Moss as lead sponsor.

NCT NCT07610967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07610967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections
Lead sponsor
David Moss
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2026
Completion date
June 30, 2028
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 respiratory infection, influenza